News

HTD Biosystems CSO Featured as Expert in AAPS Nanotechnology Session on Nanoparticle Characterization

We’re proud to announce that Dr. Mitra Mosharraf, Chief Scientific Officer at HTD Biosystems, was selected as one of the featured experts in the "Ask the Experts" session on Nanoparticle Characterization, organized by the AAPS Nanotechnology Community on January 27, 2025. This session brought together leading scientists to discuss cutting-edge techniques and best practices in the characterization of nanoparticles, critical for advancing nanomedicine and biologics.
Dr. Mosharraf shared insights drawn from over 24 years of experience in biologics and nanomedicine development, focusing on innovative strategies for ensuring the stability, efficacy, and quality of nanoparticle-based formulations.
At HTD Biosystems, we specialize in nanoparticle characterization and formulation development, offering comprehensive services for liposomes, lipid nanoparticles (LNPs), antibody-drug conjugates (ADCs), and other complex modalities. Our expertise in Design of Experiments (DoE) and advanced analytical techniques ensures robust, reproducible results, accelerating your drug development process from bench to clinic.
Ready to optimize your nanoparticle formulations?
Contact us today to learn how our expert team can support your next breakthrough.

October 7th, 2024

Participation at the AAPS PharmSci 360, Oct 20-23, Salt Lake City


Don't miss out HTD's presentations at PharmSci 360. This year HTD's president Dr. Rajiv Nayar will deliver a prologue talk on LNPs and will be the moderator for "Phase Appropriate Strategies for Gene and Cell Therapy Regulatory Compliance" session. 
Our Chief Scientific Officer,  Dr. Mitra Mosharraf, will present two scientific posters  in Salt lake City and will start her term as the Chairman of the Nanotechnology Community for 2025. Please come by our posters and let's talk about LNP stability, Protein formulation, and Lyophilization.
​​​​​​​We will also be attending a Mentoring Breakfast on Tuesday morning.

Mentoring Breakfast:
Tuesday 7 - 8:30 am, Salt Lake AB, Hyatt Regency Hotel

Prologue talk:
LNP's: Formulations that Pushed Back COVID-19​. Speaker: Dr. Rajiv Nayar

Moderator:
Dr. Rajiv Nayar will be the moderator for "Phase Appropriate Strategies for Gene and Cell Therapy Regulatory Compliance" session.
Tuesday, 9-10 am

New Chair of the Nanotechnology Community: Dr. Mitra Mosharraf
Monday 5 -6 pm, 150 DEFG

Posters:
Characterization of Protein Antigens in Liposomal Vaccines Using Differential Scanning Fluorimetry. Presenter: Dr. Mitra Mosharraf
Monday, 2:30 pm, M1430-11-60

Predicting the Aggregation Behavior of Liposomes Using Thermal Analysis.
Presenter: Dr. Mitra Mosharraf
Wednesday, 10:30 am, W1030-3-16
​​​​​​​

May 14, 2024

Exhibition & Presentations at the AAPS National Biotechnology Conference, San Francisco, CA


AAPS NBC was a great conference with a busy tradeshow, excellant program and good science. With a tradeshow, two scientific posters and a prologue talk, and lots of networking we maximized our presence at the NBC. Thank you to all who stopped by our booth and came by our posters.
  • Prologue talk: Opportunities and Challenges for Lipid-Based Drug Delivery Systems for Biopharmaceuticals.  Speaker: Dr. Rajiv Nayar
  • Poster 1:  Predicting the Aggregation Behavior of Liposomes Using Thermal Analysis. Presenter: Dr. Mitra Mosharraf
  • ​​​​​​​Poster 2: Characterization of Protein Antigens in Liposomal Vaccines Using Differential Scanning Fluorimetry. Presenter: Dr. rajiv Nayar.

Oct 26, 2023

Exhibition & Presentations at the AAPS PharmSci 360 in Orlando, FL

This year we had a wonderful tradeshow at the AAPS PharmSci 360. During this conference also HTD's president Dr. Rajiv Nayar presented a scientific poster on our COVID-19 vaccine collaboration at the AAPS PharmSci 360 in Orlando, FL. Other co-authors were Dr. Mitra Mosharraf and Dr. Aryo Sorayya.
Poster: A Versatile Room Temperature Stable Lipid Nanoparticle COVID-19 Protein-Based Vaccine.